Eric Simpson, MD, MCR: Phase 3 Trials on Roflumilast for Children with Atopic Dermatitis
November 28, 2022
While discussing Phase 3 clinical trials evaluating roflumilast cream as a potential treatment for atopic dermatitis, or eczema, Eric Simpson, M.D., M.C.R., explains he studies the skin disease because he “was drawn to helping patients and families find safe and effective solutions, (and this therapy gets us a step closer to long-term control in a safe manner.”